"Istituto Ortopedico"

During the past decade, Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors" #1 collaborator was "PharmaMar" with 5 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Cooperative Osteosarcoma Study Group" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator and "Scandinavian Sarcoma Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors" are "Osteosarcoma" (2 trials), "Soft Tissue Sarcoma" (2 trials), "Advanced Chondrosarcoma" (1 trials), "Advanced Desmoid Tumor" (1 trials) and "Advanced Soft Tissue Sarcoma" (1 trials). Many other conditions were trialed in "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors" in a lesser frequency.

Most popular intervention types in "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trabectedin" (3 trials), "ADM" (1 trials), "BUMEL" (1 trials), "CYC" (1 trials) and "Doxorubicin+cisplatin+ifosfamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".